MedTech Innovator Asia Pacific has selected 20 medtech startups for its 2026 APAC Accelerator Program, reflecting continued investor and industry interest in early-stage healthcare technologies across the region.
The cohort was selected from more than 680 applicants, placing the final 20 companies among the top 3% of this year’s applicant pool. The selection process also included 67 startups invited to pitch across the 2026 Pitch Event RoadTour, which brought together 112 unique judges and featured companies from 14 countries.
Now in its eighth year, the APAC Accelerator Program connects medical technology startups with corporate partners, investors, mentors, clinicians and industry stakeholders. The programme is designed to support commercialisation, market access and ecosystem engagement, areas that remain critical for startups seeking to move from product development into clinical adoption.
The selected companies span multiple markets, including South Korea, China, Pakistan, Denmark, Australia, the United States, India, Japan and Singapore. The cohort includes companies working across areas such as digital health, diagnostics, surgical technologies, AI-enabled healthcare and patient care solutions.
The programme will run from June to October 2026. Participating companies will begin at the Innovator Summit from June 3 to 4 in San Francisco, followed by the Wilson Sonsini Medical Device Conference on June 5. The programme will conclude at the 2026 APAC Grand Finals on October 26 in Singapore, where selected companies will compete for up to USD 275,000 in cash prizes.
The accelerator is supported by industry and government partners including Johnson & Johnson MedTech, B. Braun Medical Industries, Siemens Healthineers, Blue Goat Cyber, FormlyAI, KHIDI, Enterprise Singapore, Cambridge Consultants and The Mullings Group. Such partnerships are particularly relevant in medtech, where regulatory strategy, clinical validation, manufacturing readiness and reimbursement pathways can significantly influence commercial outcomes.
MedTech Innovator has reviewed more than 14,000 applications and supported 838 portfolio companies, which have collectively raised more than USD 11.4 billion in follow-on funding. Since launching in 2019, MedTech Innovator Asia Pacific has supported startups across 20 countries in the region, with 154 APAC alumni raising more than USD 335 million.
